Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Net Sales	$ 13,637	$ 15,109	$ 42,869	$ 45,888
Cost of sales	11,368	12,928	35,853	38,596
Research and development expenses	434	402	1,245	1,213
Selling, general and administrative expenses	739	691	2,120	2,086
Amortization of intangibles	117	125	361	373
Restructuring charges	0	0	357	0
Acquisition-related integration expenses	0	0	0	31
Equity in earnings of nonconsolidated affiliates	175	375	492	964
Sundry income (expense) - net	(21)	47	23	(322)
Interest income	10	9	26	26
Interest expense and amortization of debt discount	318	305	959	1,010
Income Before Income Taxes	825	1,089	2,515	3,247
Provision for income taxes	234	186	664	546
Net Income	591	903	1,851	2,701
Net income attributable to noncontrolling interests	9	3	38	24
Net Income attributable to The Dow Chemical Company	582	900	1,813	2,677
Preferred stock dividends	85	85	255	255
Net Income Available for The Dow Chemical Company Common Stockholders	497	815	1,558	2,422
Per Common Share Data:
Earnings per common share - basic	$ 0.42	$ 0.70	$ 1.32	$ 2.08
Earnings per common share - diluted	$ 0.42	$ 0.69	$ 1.31	$ 2.07
Common stock dividends declared per share of common stock	$ 0.32	$ 0.25	$ 0.89	$ 0.65
Weighted-average common shares outstanding - basic	1,172.7	1,152.3	1,167.8	1,147.2
Weighted-average common shares outstanding - diluted	1,179.5	1,160.9	1,174.9	1,157.8
Depreciation	514	539	1,530	1,624
Capital Expenditures	$ 622	$ 651	$ 1,605	$ 1,620